may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..

"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have.

cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months..

while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..

treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk..